Medical Technology Company Secures Partnership With Government Services For Veteran Treatment
Transforming Veteran Care: The Revolutionary Partnership Between Helius Medical Technologies and Lovell Government Services.
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any agency of the U.S. government. Information is based on sources believed to be reliable; however, their accuracy, completeness, and reliability cannot be guaranteed.
In a groundbreaking development that promises to redefine the treatment landscape for veterans suffering from multiple sclerosis (MS), Helius Medical Technologies, Inc., has announced a partnership with Lovell Government Services. This collaboration aims to significantly expand the reach of PoNS Therapy™, an innovative neuromodulation treatment, within federal healthcare systems, notably benefiting the veteran community.
MS, a condition that affects the central nervous system, can lead to severe physical and cognitive impairments, including difficulties with gait and balance. The Department of Veterans Affairs reports over 28,000 cases of MS annually, underscoring the urgent need for effective treatment options. Enter the Portable Neuromodulation Stimulator (PoNS®) device, a non-implantable, orally applied therapy developed by Helius Medical Technologies. When used in conjunction with physical therapy, PoNS Therapy™ offers a novel approach to treating balance and gait deficits in adults with mild-to-moderate symptoms of MS.
Lovell Government Services, an SBA-certified Service Disabled Veteran Owned Small Business (SDVOSB), plays a crucial role in this partnership. As an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD), Lovell will facilitate the availability of the PoNS device across federal healthcare systems. This initiative aligns with Lovell’s mission to introduce innovative and effective resources to federal healthcare providers, thereby enhancing the quality of care available to veterans.
Real-World Impact and Testimonials
The potential benefits of PoNS Therapy™ for the veteran community cannot be overstated. In a study mentioned in the announcement, 100% of MS patients experienced a clinically meaningful improvement in gait after 14 weeks of treatment. The real-life story of Kevin Byrne, a retired U.S. veteran, further illustrates the transformative impact of PoNS Therapy™. After undergoing treatment, Byrne reported significant improvements in walking, enabling him to enjoy quality adventures with his daughter once again.
Both Helius Medical Technologies and Lovell Government Services have expressed their enthusiasm about the partnership's potential to change lives. Dane Andreeff, President and CEO of Helius, described PoNS Therapy™ as a "game changer" for veterans and their families. Chris Lovell, CEO of Lovell Government Services, echoed these sentiments, emphasizing the importance of providing veterans with access to the most advanced medical resources.
As this partnership unfolds, it heralds a new chapter in the treatment of MS, offering hope and improved quality of life for veterans affected by this challenging condition. By leveraging cutting-edge technology and fostering collaboration between public and private sectors, Helius Medical Technologies and Lovell Government Services are setting a precedent for innovation in veteran healthcare.
For veterans and healthcare providers seeking more information about PoNS Therapy™ and its availability, please visit the official Helius Medical Technologies website.
This partnership represents not just a step forward in MS treatment but a leap towards a future where veterans facing the challenges of MS have access to the care and support they deserve.